| Sandoz Pharmaceuticals AG - Etoricoxib Sandoz 30 mg, Filmtabletten | | 67853 | | 01 | | Etoricoxib Sandoz 30 mg | | Filmtabletten | | M01AH05 | | Etoricoxib | | 06.08.2021 | | |
| | Composition | | etoricoxibum 30 mg, calcii hydrogenophosphas, cellulosum microcristallinum, povidonum, magnesii stearas, carmellosum natricum conexum, Überzug: hypromellosum, lactosum monohydricum 0.560 mg, triacetinum, E 132, E 171, E 172 (flavum), pro compresso obducto corresp. natrium 63.7 µg. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| | 30 mg |
| | BAG: Principe actif | Concentr. |
|---|
| | 30 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| | | | | Calcium Hydrogenophosphate | | | | | | | | | | | | | | color. | | | | color. | | | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 0.56 mg | | | | | | | Povidone | | | | | | | | | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 28 | 13.99 | 31.65 | B | LS | Non |
|
|
